The term amyloidosis refers to a group of disorders in which protein fibrils accumulate in
certain organs, disrupt their tissue architecture, and impair the function of the effected organ …

Since the mid-nineteenth century pathology has followed the convoluted story of
amyloidosis, recognized its morphology in tissues and made identification possible using …

Renal amyloidosis is a rare condition caused by the progressive accumulation of misfolded
proteins within glomeruli, vessels, and interstitium, causing functional decline and requiring …

Aims Identification and characterisation of monoclonal gammopathies of renal significance
(MGRS) is critical for therapeutic purposes. Amyloidosis represents one of the most common …

Background In systemic amyloidosis, the kidney is frequently affected and renal involvement
has a major impact on survival. Renal involvement is clinically characterized by decreased …

Background Advancements in treatment regimens have led to improved outcomes in renal
Immunoglobulin light-chain amyloidosis. Nevertheless, a subset of patients may still …

Abstract Background Cardiac AL and ATTR are potentially fatal cardiomyopathies. Current
therapies do not address mechanisms of tissue dysfunction because these remain unknown …

Background Patients with restless legs syndrome (RLS) have increased silent microvascular
disease by magnetic resonance imaging. However, there has been no previous autopsy …

Amyloidosis is a group of complex diseases caused by the misfolding and aggregation of
proteins into amyloid fibrils. Light-chain (AL) amyloidosis is one of the most prevalent forms …

4例重链或轻重链肾淀粉样变性患者的临床病理特点- PMC Back to Top Skip to main content
NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …